Primo Brands vs SRX Global
PRMB and SRXH side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How PRMB and SRXH compare
Primo Brands pays a dividend yielding 1.9%; SRX Global does not pay one.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | PRMB | SRXH |
|---|---|---|
| Size and price | ||
| Market cap | $8.7B | – |
| Share price | $24.05 | $0.931 |
| Change, 1 year | 47.5% | −93.6% |
| Change, 5 years | 37.5% | −100.0% |
| Beta (5Y) | 1.09 | 1.46 |
| Employees | 13K | – |
| StockData Score | ||
| Total score | 10 | – |
| Valuation score | 2 | – |
| Growth score | 3 | – |
| Performance score | 1 | – |
| Health score | 1 | – |
| Dividend score | 3 | – |
| Valuation | ||
| P/E | 42.9× | – |
| P/S | 1.3× | – |
| P/B | 2.9× | – |
| EV/EBITDA | 11.3× | – |
| P/FCF | 21.1× | – |
| FCF yield | 4.7% | – |
| Fair value | $26.10 | – |
| Margin of safety | 7.9% | – |
| Growth | ||
| Revenue growth (TTM) | 4.5% | – |
| Profitability | ||
| Gross margin | 29.4% | – |
| Operating margin | 8.6% | – |
| Net margin | 3.1% | – |
| FCF margin | 6.1% | – |
| Return on equity | 6.7% | – |
| Return on invested capital | 5.1% | – |
| Financial health | ||
| Debt / equity | 1.69 | – |
| Net debt / EBITDA | 3.94 | – |
| Interest coverage | 1.8× | – |
| Current ratio | 1.11 | – |
| Altman Z-score | 1.24 | – |
| Piotroski F-score | 4 | – |
| Dividends and buybacks | ||
| Dividend yield | 1.9% | – |
| Payout ratio | 81.4% | – |
| Years of dividend growth | 1 | – |
| Buyback yield | 2.1% | – |
| Shareholder yield | 4.0% | – |
| Ownership | ||
| Held by institutions | 110% | 4.0% |
| Held by insiders | 59.9% | 11.3% |
| Insider net buying, 12 months | −$993M | – |
| Superinvestors holding | 2 | – |
| Short interest, % of float | 20.2% | 5.6% |
Go deeper
- PRMB stock overview
- PRMB income statement
- PRMB valuation and score
- SRXH stock overview
- SRXH income statement
- SRXH valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.